繁中EN
Abstract cellular science scene (AI-generated illustration)

Insights

Understand the Research and Its Limits

Explore scientific evidence, company news and pet care knowledge.

Library

Explore by Category

External research and company updates are presented separately. Research findings do not validate company products or services.

Selected External Research

Research Moves Forward. Interpretation Needs Context.

Selected studies from 2025–2026, updated through October 18, 2026; not a complete systematic review. In vitro research, healthy-animal observations and clinical trials in naturally occurring disease are labeled separately.

Feline Cells · In Vitro

Cytokine Priming of Feline MSCs: New In Vitro Findings

The study observed changes in mitochondrial structure and vesicle RNA composition, providing leads for process research.

Key context: Molecular and cellular changes do not establish efficacy against feline disease or show that different processes and products have equivalent effects.

Study Design & Sources
Design & Sample
Placenta-derived MSCs from seven healthy cats were compared under different culture conditions. No treatment trial in diseased cats was conducted.
Cells & Methods
Control, serum-free and inflammatory cytokine-stimulated conditions were compared. Cells and their secreted extracellular vesicles were analyzed; this was not a clinical exosome injection study.
Safety
In vitro cell viability observations cannot replace safety assessment of administration to animals.
Verification Scope
Abstract verified; full text unavailable

American Journal of Veterinary Research
DOI:10.2460/ajvr.26.05.0197 | PMID:42833257

Journal Article PubMed Record
Cats · Naturally Occurring Disease

Feline Osteoarthritis: A Randomized Controlled Pilot in 35 Cats

Both cell groups showed improvement signals in several owner and veterinarian assessments, warranting further research.

Key context: Groups included approximately ten cats each, with short follow-up and potentially expectation-influenced owner scores. A pilot trial cannot establish long-term effects.

Study Design & Sources
Design & Sample
Six practices and 35 cats; randomized, blinded and placebo-controlled, with 90-day follow-up.
Cells & Methods
Feline allogeneic uterine-derived MSCs administered intravenously.
Safety
Transient vomiting, nausea, weakness and other events were recorded. Tolerability observations do not mean treatment is risk-free.
Verification Scope
Full text verified

Frontiers in Veterinary Science
DOI:10.3389/fvets.2026.1900571 | PMID:42761244

Journal Article PubMed Record
Multispecies Literature Review

Veterinary MSC Clinical Evidence: Where Are the Gaps?

The authors describe a larger evidence base for some musculoskeletal conditions; other areas still consist mainly of pilot trials and case series.

Key context: Differences in species, cell sources, doses and outcomes prevent a single pooled success rate. Equine findings cannot be applied directly to dogs and cats.

Study Design & Sources
Design & Sample
A review of veterinary clinical studies in naturally occurring disease, not a single canine or feline trial. The date shown is the online publication date.
Cells & Methods
Different MSC sources and preparations are reviewed. Extracellular vesicles are also discussed and must not be treated as the same intervention.
Safety
The review does not establish the safety of any particular cell product.
Verification Scope
Abstract verified; full text unavailable

The Veterinary Journal
DOI:10.1016/j.tvjl.2026.106837 | PMID:42624276

Journal Article PubMed Record
Cats · Randomized Controlled Study

Feline Chronic Gingivostomatitis: A Trial Showing No Superiority to Control

Under this study's design and dosing conditions, disease activity and other measures did not show evidence of superiority to control.

Key context: The sample was small and dosing was limited to one administration. Findings apply to those study conditions and do not establish that all MSC approaches are effective or ineffective.

Study Design & Sources
Design & Sample
Sixteen cats at one practice; randomized, blinded and placebo-controlled, with primary follow-up to approximately day 84.
Cells & Methods
A single intravenous dose of equine peripheral blood-derived MSCs, a xenogeneic cell source.
Safety
Each group had one adverse event and one serious adverse event, judged unrelated to administration by investigators. Industry funding was also disclosed.
Verification Scope
Full text verified

Frontiers in Veterinary Science
DOI:10.3389/fvets.2026.1857014 | PMID:42375508

Journal Article PubMed Record
Cats · Open-label Extension

Refractory Feline Gingivostomatitis: Safety Follow-up to One Year

The authors reported that some owner-assessed and oral lesion improvements persisted to one year. The study primarily contributes longer-term safety observations.

Key context: Concurrent medication was allowed and there was no concurrent control. This extension of the original trial is not a fully independent second source of efficacy evidence.

Study Design & Sources
Design & Sample
Thirty-five cats in a multicenter open-label extension of an earlier trial, followed to day 365, without a concurrent placebo group.
Cells & Methods
Feline allogeneic uterine-derived MSCs. Cell administration was completed in the original trial; no further doses were given during the extension.
Safety
No serious events related to cell administration were reported, although transient nausea, vomiting and other reactions were recorded.
Verification Scope
Abstract verified; full text unavailable

Journal of Feline Medicine and Surgery
DOI:10.1177/1098612X261431058 | PMID:41757710

Journal Article PubMed Record
Cell Processes + Healthy Dogs

Canine Synovial Fluid MSCs: Process Feasibility and Safety First

The study demonstrated culture and preparation feasibility. No abnormalities were observed in the assessed measures in three healthy dogs.

Key context: This was not a controlled efficacy trial in dogs with osteoarthritis. Healthy-dog observations do not establish pain relief or cartilage repair.

Study Design & Sources
Design & Sample
Cells were obtained from dogs undergoing orthopedic surgery. A separate safety assessment involved intra-articular administration in three healthy dogs with 90-day follow-up.
Cells & Methods
Canine synovial fluid / joint lavage-derived MSCs, studied through allogeneic intra-articular administration.
Safety
A safety sample of only three dogs cannot exclude rare or longer-term risks.
Verification Scope
Abstract verified; full text unavailable

Research in Veterinary Science
DOI:10.1016/j.rvsc.2025.105897 | PMID:40974968

Journal Article PubMed Record

These are summaries of external literature. Differences in species, cell sources and methods prevent direct conclusions about company products or services. They do not replace individual veterinary assessment.

Discuss Research or Professional Collaboration Explore Technology & Research